Taylor Steiner
Associate Director
Crafter of investor relations programs and strategic corporate narratives that effectively position biopharmaceutical companies for fair market valuation. Expertise in late-stage data readouts, public listings (IPOs and SPACs), and an array of financing processes. Focus on central nervous system, oncology, autoimmune diseases, and rare disease.
Secret passions
Cheering on the New York Rangers and keeping her DuoLingo streak alive